Efficacy and Safety Study of Isuzinaxib in Subjects With DKD

Clinical trial NCT06962098 · RECRUITING

Trial details

NCT number: NCT06962098
Sponsor: Aptabio Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Kidney Disease (DKD)

Start date: 2025-05-26
Primary completion: 2027-06-30
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.